CAAS
CELU icon

Capital Asset Advisory Services’s Celularity CELU Stock Holding History

Capital Asset Advisory Services’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,500
Closed -$6.18K – 317
2023
Q4 		$6.18K Sell
2,500
-100
-4% -$217 ﹤0.01% 306
2023
Q3 		$6.11K Buy
+2,600
New +$9.34K ﹤0.01% 312

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return

Capital Asset Advisory Services's CELU Position: Q1 2024 in Review

Capital Asset Advisory Services sold out of Celularity (CELU) in Q1 2024, closing a stake of 2,500 shares — an estimated $6.18K sold.

Capital Asset Advisory Services first reported a position in CELU in Q3 2023 and held it in 2 quarters. The position peaked at $6.18K in Q4 2023. 30 funds tracked by Wall St. Rank hold CELU as of Q1 2024.

  • Capital Asset Advisory Services reported no remaining Celularity position as of Q1 2024 after selling out during the quarter.
  • Capital Asset Advisory Services sold 2,500 Celularity shares in Q1 2024, an estimated $6.18K.
  • Capital Asset Advisory Services first reported a position in Celularity in Q3 2023 and held it in 2 quarters.
  • Capital Asset Advisory Services's Celularity position peaked at $6.18K in Q4 2023.
  • 30 funds tracked by Wall St. Rank held Celularity as of Q1 2024.

Based on Capital Asset Advisory Services's 13F filing for Q1 2024, filed 16 Apr 2024.